Open AccessHER2-mutiertes NSCLC: Trastuzumab Deruxtecan besser niedrig dosieren
Author(s) -
Josef Gulden
Publication year - 2022
Publication title -
deutsches ärzteblatt
Language(s) - Uncategorized
Resource type - Journals
eISSN - 0172-2107
pISSN - 0012-1207
DOI - 10.3238/persesmo.2022.10.14.07
Subject(s) - trastuzumab , medicine , oncology , breast cancer , cancer